1. Home
  2. CEP vs BDTX Comparison

CEP vs BDTX Comparison

Compare CEP & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CEP
  • BDTX
  • Stock Information
  • Founded
  • CEP 2020
  • BDTX 2014
  • Country
  • CEP United States
  • BDTX United States
  • Employees
  • CEP N/A
  • BDTX N/A
  • Industry
  • CEP
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CEP
  • BDTX Health Care
  • Exchange
  • CEP NYSE
  • BDTX Nasdaq
  • Market Cap
  • CEP 130.7M
  • BDTX 144.9M
  • IPO Year
  • CEP 2024
  • BDTX 2020
  • Fundamental
  • Price
  • CEP $10.47
  • BDTX $2.53
  • Analyst Decision
  • CEP
  • BDTX Strong Buy
  • Analyst Count
  • CEP 0
  • BDTX 4
  • Target Price
  • CEP N/A
  • BDTX $15.50
  • AVG Volume (30 Days)
  • CEP 42.5K
  • BDTX 476.4K
  • Earning Date
  • CEP 01-01-0001
  • BDTX 11-05-2024
  • Dividend Yield
  • CEP N/A
  • BDTX N/A
  • EPS Growth
  • CEP N/A
  • BDTX N/A
  • EPS
  • CEP 0.06
  • BDTX N/A
  • Revenue
  • CEP N/A
  • BDTX N/A
  • Revenue This Year
  • CEP N/A
  • BDTX N/A
  • Revenue Next Year
  • CEP N/A
  • BDTX N/A
  • P/E Ratio
  • CEP $191.76
  • BDTX N/A
  • Revenue Growth
  • CEP N/A
  • BDTX N/A
  • 52 Week Low
  • CEP $9.99
  • BDTX $2.31
  • 52 Week High
  • CEP $10.95
  • BDTX $7.66
  • Technical
  • Relative Strength Index (RSI)
  • CEP N/A
  • BDTX 43.96
  • Support Level
  • CEP N/A
  • BDTX $2.43
  • Resistance Level
  • CEP N/A
  • BDTX $2.66
  • Average True Range (ATR)
  • CEP 0.00
  • BDTX 0.16
  • MACD
  • CEP 0.00
  • BDTX 0.05
  • Stochastic Oscillator
  • CEP 0.00
  • BDTX 48.81

About CEP CANTOR EQUITY PARTNERS INC

Cantor Equity Partners Inc is a blank check company.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Share on Social Networks: